---
document_datetime: 2024-07-12 13:43:26
document_pages: 8
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/bortezomib-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: bortezomib-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 5.1874223
conversion_datetime: 2025-12-24 22:35:32.082835
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Bortezomib Accord

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                    | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0034               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                         | 08/07/2024                          |                                             | PL                               |           |
| IA/0033              | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or | 04/12/2023                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                   | intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                                                                                                                                                                                                                                            |            |            |              |                                   |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|--------------|-----------------------------------|
| PSUSA/424/2 02304 | Periodic Safety Update EU Single assessment - bortezomib                                                                                                                                                                                                                                                                                                                                                                       | 30/11/2023 | n/a        |              | PRAC Recommendation - maintenance |
| IA/0031/G         | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place | 08/03/2023 | n/a        |              |                                   |
| IA/0030           | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                               | 17/02/2023 | n/a        |              |                                   |
| IB/0029           | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                      | 25/03/2022 | 09/12/2022 | SmPC         |                                   |
| IB/0027           | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                      | 20/12/2021 | 09/12/2022 | SmPC         |                                   |
| IA/0028           | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                  | 13/12/2021 | 09/12/2022 | Annex II and |                                   |

<div style=\"page-break-after: always\"></div>

|                   |                                                                                                                                                                                                                                                                                                                                                         |            |            | PL                               |                                                                                                                                          |
|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|
| X/0023            | Annex I_2.(c) Change or addition of a new strength/potency Annex I_2.(d) Change or addition of a new pharmaceutical form                                                                                                                                                                                                                                | 20/05/2021 | 23/07/2021 | SmPC, Annex II, Labelling and PL |                                                                                                                                          |
| PSUSA/424/2 02004 | Periodic Safety Update EU Single assessment - bortezomib                                                                                                                                                                                                                                                                                                | 10/12/2020 | 18/02/2021 | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/424/202004. |
| IAIN/0026/G       | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing A.7 - Administrative change - Deletion of manufacturing sites | 22/12/2020 | 23/07/2021 | Annex II and PL                  |                                                                                                                                          |
| IB/0024           | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                           | 07/05/2020 | 18/02/2021 | Annex II                         |                                                                                                                                          |
| R/0022            | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                 | 27/02/2020 | 04/05/2020 | SmPC, Annex II, Labelling and PL |                                                                                                                                          |
| PSUSA/424/2 01904 | Periodic Safety Update EU Single assessment - bortezomib                                                                                                                                                                                                                                                                                                | 28/11/2019 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                        |
| IB/0020           | B.II.b.4.z - Change in the batch size (including batch                                                                                                                                                                                                                                                                                                  | 10/07/2019 | n/a        |                                  |                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

|                   | size ranges) of the finished product - Other variation                                                                                                                                                                                                       |            |            |                        |                                                                                                                                          |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0018           | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 25/03/2019 | 03/04/2020 | SmPC                   |                                                                                                                                          |
| IAIN/0019         | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                       | 05/03/2019 | 03/04/2020 | Annex II and PL        |                                                                                                                                          |
| T/0017            | Transfer of Marketing Authorisation                                                                                                                                                                                                                          | 11/01/2019 | 25/02/2019 | SmPC, Labelling and PL |                                                                                                                                          |
| PSUSA/424/2 01804 | Periodic Safety Update EU Single assessment - bortezomib                                                                                                                                                                                                     | 13/12/2018 | 20/02/2019 | SmPC and PL            | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/424/201804. |
| II/0014           | B.I.a.1.b - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introduction of a manufacturer of the AS supported by an ASMF                                                                                           | 17/01/2019 | n/a        |                        |                                                                                                                                          |
| IAIN/0016/G       | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                        | 16/10/2018 | 20/02/2019 | Annex II and PL        |                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

|                   | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - Including batch control/testing   |            |            |                                  |                                   |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| X/0008            | Annex I_2.(c) Change or addition of a new strength/potency                                                                                                                                                                                                                                                                                                                     | 22/03/2018 | 28/05/2018 | SmPC, Annex II, Labelling and PL |                                   |
| IAIN/0013         | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                         | 17/04/2018 | n/a        |                                  |                                   |
| II/0012           | B.II.b.4.d - Change in the batch size (including batch size ranges) of the finished product - The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes                                                                                                                                                                             | 18/01/2018 | n/a        |                                  |                                   |
| PSUSA/424/2 01704 | Periodic Safety Update EU Single assessment - bortezomib                                                                                                                                                                                                                                                                                                                       | 30/11/2017 | n/a        |                                  | PRAC Recommendation - maintenance |
| IB/0010           | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by                                                                                                                           | 10/07/2017 | 28/05/2018 | SmPC, Annex II, Labelling and PL |                                   |

<div style=\"page-break-after: always\"></div>

|           | the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |            |                     |                    |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|---------------------|--------------------|
| IB/0009/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.2.z - Change in test procedure for AS or material/reagent/intermediate - Other | 29/05/2017 | n/a        |                     | starting variation |
| IA/0007   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 14/09/2016 | n/a        |                     |                    |
| IB/0006/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 06/04/2016 | 02/05/2016 | SmPC, Labelling and |                    |

<div style=\"page-break-after: always\"></div>

|             | generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   |            |     | PL   |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|
| IA/0005     | B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 29/03/2016 | n/a |      |
| II/0001     | B.II.b.4.d - Change in the batch size (including batch size ranges) of the finished product - The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 19/11/2015 | n/a |      |
| IAIN/0003/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 21/08/2015 | n/a |      |

<div style=\"page-break-after: always\"></div>

|         | site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing   |            |     |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0002 | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                    | 18/08/2015 | n/a |